A New Benchmark for Modern Management of Valvular Heart Disease: The Whole-Life Cycle Management System

Area of Science:

• Cardiology
• Public Health
• Health Systems Research

Background:

• Valvular heart disease (VHD) prevalence is rising globally, straining healthcare systems.
• Despite advances, VHD diagnosis, treatment, and follow-up rates are low, particularly in low- and middle-income countries.
• Existing care models inadequately address elderly patients, those with comorbidities, and postoperative VHD management, leading to poor outcomes.

Purpose of the Study:

• To review deficiencies in the Chinese healthcare system for treating valvular heart disease.
• To introduce and discuss the whole-life cycle management system for VHD patients.

Main Methods:

• Literature review on VHD prevalence, management, and treatment gaps.
• Analysis of VHD care within the Chinese healthcare system.
• Description of the whole-life cycle management system for VHD.

Main Results:

• Significant disparities exist in VHD detection, intervention, and follow-up rates globally and within China.
• Current management strategies are insufficient for specific patient groups, increasing mortality and morbidity.
• The whole-life cycle management system is proposed to address these deficiencies.

Conclusions:

• Addressing VHD requires systemic improvements and targeted interventions.
• The whole-life cycle management system offers a promising framework to enhance VHD patient survival and prognosis.
• Increased public and policy attention is crucial for effective VHD management.